Clinical Trial Update: Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating autologous adipose-derived mesenchymal stem cells for spinal cord injury is currently active but not recruiting, sponsored by Mayo Cl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: Spinal Cord Injuries, Paralysis | Phase 2 | Status: ACTIVE_NOT_RECRUITING